Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 3 | United Kingdom | 21 Aug 2021 | |
| B-Cell Lymphoma | Phase 1 | United Kingdom | 21 Aug 2021 | |
| T-Cell Lymphoma | Phase 1 | United Kingdom | 21 Aug 2021 |





